The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of levetiracetam as a sensitizer of temozolomide for newly diagnosed glioblastoma: A prospective, open-label, phase II study (KBTS-1601 study).
 
Chae-Yong Kim
No Relationships to Disclose
 
Kihwan Hwang
No Relationships to Disclose
 
Jong Hee Chang
No Relationships to Disclose
 
Seok-Gu Kang
No Relationships to Disclose
 
Tae-Young Jung
No Relationships to Disclose
 
Jeong Hoon Kim
No Relationships to Disclose
 
Se-Hyuk Kim
No Relationships to Disclose
 
Shin-Hyuk Kang
No Relationships to Disclose
 
Yong-Kil Hong
No Relationships to Disclose
 
Tae Min Kim
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Bayer; Boryung; Novartis; Sanofi; Takeda; Voronoi Health Analytics
 
Byung Se Choi
No Relationships to Disclose
 
YuJung Kim
No Relationships to Disclose
 
Ghee Young Choe
No Relationships to Disclose